|
|
Volumn 85, Issue 3, 2000, Pages 1107-1113
|
|
Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer
a
a
a
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
IODINE 131;
THYROGLOBULIN;
DIAGNOSTIC AGENT;
RADIOACTIVE IODINE;
RADIOPHARMACEUTICAL AGENT;
ADULT;
AGE;
AGED;
ARTICLE;
CANCER SURVIVAL;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
FEMALE;
FOLLOW UP;
GENDER;
HIGH RISK PATIENT;
HUMAN;
IODINE 131 UPTAKE TEST;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
MULTIVARIATE ANALYSIS;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROGNOSIS;
THYROGLOBULIN BLOOD LEVEL;
THYROID CANCER;
WHOLE BODY SCINTISCANNING;
ANALYSIS OF VARIANCE;
CLINICAL TRIAL;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
MIDDLE AGED;
PATHOLOGY;
RETROSPECTIVE STUDY;
SCINTISCANNING;
SEX DIFFERENCE;
SURVIVAL;
THYROID TUMOR;
ADULT;
AGE FACTORS;
ANALYSIS OF VARIANCE;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
IODINE RADIOISOTOPES;
MALE;
MIDDLE AGED;
PROGNOSIS;
RADIOPHARMACEUTICALS;
RETROSPECTIVE STUDIES;
SEX FACTORS;
SURVIVAL ANALYSIS;
THYROID NEOPLASMS;
TOMOGRAPHY, EMISSION-COMPUTED;
|
|
EID: 0034335410
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jc.85.3.1107 Document Type: Article |
|
Times cited : (337)
|
|
References (38)
|
